GlassScriptPhysician profile
Bruce S Sand
NPI 1093826521
$1,259.31
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.25 · 2021: $93.54 · 2022: $184 · 2023: $562 · 2024: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $969.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $292.77 | 2020-2023 | Skyrizi, Rinvoq |
| Boston Scientific Corporation | $243.73 | 2021-2024 | |
| Madrigal Pharmaceuticals | $144.22 | 2024 | Rezdiffra |
| Medtronic, INC. | $138.57 | 2022 | |
| Genzyme Corporation | $131.31 | 2023-2024 | |
| Regeneron Healthcare Solutions, INC. | $127.03 | 2023 | Dupixent |
| Intercept Pharmaceuticals, INC. | $113.37 | 2023 | Ocaliva |
| Intuitive Surgical, INC. | $32.00 | 2023 | Da Vinci Surgical System |
| Conmed Corporation | $19.71 | 2023 | Airseal |
| Gilead Sciences, INC. | $15.23 | 2021 | |
| Intra-Sana Laboratories | $1.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Sand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.